Concepedia

Lakshmi Pendyala

LP

Statistics

Publications

58

Citations

2.5K

H-Index

30

Active since

1969

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Immunovaccine (Canada)

University at Buffalo, State University of New York

Lakshmi Pendyala is an author at Roswell Park Comprehensive Cancer Center specializing in oncology, chemotherapy, and pharmacology.

Publications per year

1969–2010

58

Publications

58

In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin.

Lakshmi Pendyala, Patrick J. Creaven · PubMed · 1993 · 209 citations

, , +17

VX-710 (Biricodar) Increases Drug Retention and Enhances Chemosensitivity in Resistant Cells Overexpressing P-Glycoprotein, Multidrug Resistance Protein, and Breast Cancer Resistance Protein

Hans Minderman, Kieran L. O’Loughlin, Lakshmi Pendyala et al. · Clinical Cancer Research · 2004 · 169 citations · Full text

, , +17

In vitro studies on the mechanisms of oxaliplatin resistance

Suzanne Hector, Wanda Bolanowska-Higdon, Joseph Zdanowicz et al. · Cancer Chemotherapy and Pharmacology · 2001 · 154 citations

, , +14

Oxaliplatin in Combination With Protracted-Infusion Fluorouracil and Radiation: Report of a Clinical Trial for Patients With Esophageal Cancer

Nikhil I. Khushalani, Cynthia G. Leichman, Gary M. Proulx et al. · Journal of Clinical Oncology · 2002 · 118 citations

, , +17

The Role of DNA Polymerase η in Translesion Synthesis Past Platinum–DNA Adducts in Human Fibroblasts

Ekaterina Bassett, Nicole M.King, Miriam F. Bryant et al. · Cancer Research · 2004 · 103 citations · Full text

, , +14

1–5 of 58